The pentapeptide proctolin (Proct.; Arg-Tyr-Leu-Pro-Thr) is a modulatory transmitter found throughout the crustacean nervous system. No information is available in this system, however, as to how the actions of this peptide are terminated. To study this issue in the crab Cancer borealis, we incubated exogenous proctolin (1 O-5 M) with either the thoracic ganglion (TG) or with conditioned saline (CS) that had been preincubated with the TG. We removed aliquots at standard time points for analysis by reverse-phase highperformance liquid chromatography (HPLC). We found that over time the proctolin peak became progresstvely smaller, while three novel peaks appeared and increased in size. Comigration experiments using HPLC indicated that the major novel peak was Proct. [2-51 (Tyr-Leu-Pro-Thr), while one of the two minor peaks was Proct. [3-51 (Leu-Pro-Thr).
The other minor peak appeared to be Proct. [l-2] (Arg-Tyr), based on similar HPLC retention time to synthetic Proct. [l-2] . The reduction in the proctolin peak and the increase in the Proct. [2-51 peak was prevented by co-incubation of proctolin with any one of several aminopeptidase inhibitors (lo-' M). Proct. [l-2] and Proct. [3-51 appeared to result from a diaminopeptidase-mediated cleavage of proctolin. We tested whether Kterminal cleavage functionally inactivated proctolin by coapplying proctolin (10~~ M) and individual aminopeptidase inhibitors (1O-5 M) to the isolated stomatogastric ganglion (STG). We found that these inhibitors significantly enhanced the proctolin excitation of the pyloric rhythm. Furthermore, application of synthetic Proct. [2-51 to the STG had no effect unless high concentrations (> 1 Om6 M) were used, and neither Proct. [l-2] nor Proct. [3-51 (lOma M) influenced the pyloric rhythm. Our results indicate that proctolin is enzymatically degraded and thereby biologically inactivated in the crab nervous system, primarily by extracellularly located aminopeptidase activity.
Considerable information is available regarding the presence, synthesis, release, and postsynaptic effects of neuropeptide transmitters (White et al., 1985; Polak and Bloom, 1987; Sossin et al., 1989; DeLoof and Schoofs, 1990; Marder and Weimann, 1992) . Less is known regarding the postrelease fate of these peptides, and how that fate influences synaptic transmission. Thus far, it has been shown that intact neuropeptides can diffuse relatively long distances from their release sites (Jan and Jan, 1982; Mayeri et al., 1985) or can be enzymatically cleaved in the extracellular space (McKelvy and Blumberg, 1986; Isaac, 1987 Isaac, , 1988 Turner, 1987; Molineaux et al., 1988; Rose et al., 1988; Squire et al., 1991) . In some systems, extracellular cleavage functionally inactivates the neuropeptide (Turner et al., 1985; Hall and Lloyd, 1990; Owens et al., 1992) . This inactivation limits the duration and distance over which the peptide influences its targets (Sigvardt et al., 1986) . Sometimes, however, enzymatic cleavage either activates or enhances the physiological effects of the peptide (Turner et al., 1985; Thorsett and Wyvratt, 1987; Owens et al., 1992) . While some information is available regarding how neuropeptide inactivation influences peptidergic effects at both the cellular (Sigvardt et al., 1986; Owens et al., 1992) and the behavioral level (Turner et al., 1985; Sullivan et al., 1988; Hall and Lloyd, 1990) little is known about the role played by neuropeptide inactivation in sculpting peptidergic modulation of neural network activity.
One well-studied model system for neuropeptide actions on rhythmically active networks is the crustacean stomatogastric nervous system (STNS; Harris-Wanick et al., 1992b; Marder and Weimann, 1992; Weimann et al., 1993) . One particularly well-characterized rhythmic motor pattern in this system is the pyloric rhythm, generated by a neural network in the stomatogastric ganglion (STG; Selverston and Moulins, 1987; HarrisWarrick et al., 1992a) . The pyloric rhythm is influenced by many different modulatory transmitters, including at least six different neuropeptides (Harris-Warrick et al., 1992b; Marder and Weimann, 1992) . Among the best-characterized neuropeptides in the STNS is the pentapeptide proctolin (Proct.; Arg-Tyr-LeuPro-Thr; Marder et al., 1986) , which is also found throughout the crustacean CNS (Schwarz et al., 1984; Siwicki and Bishop, 1986 ). Exogenously applied proctolin causes a dose-dependent excitation of the pyloric rhythm (Marder et al., 1986; Hooper and Marder, 1987; Nusbaum and Marder, 1989a,b; Golowasch and Marder, 1992) . Within the STNS, proctolin is found in the STG neuropil, in several fibers entering the STG, and in somata in the neighboring commissural (COGS) and esophageal (OG) ganglia. In the crab Cancer borealis there appear to be only three solution plus 20 ~1 of HCI. These samples were analyzed with a Vydac C,, HPLC analytical column (0.46 x 25 cm, 300 8, pore size) to which was fitted a Vydac C,, guard column and a precolumn filter. Samples were analyzed with 0. II trifluoroacetic acid (TFA, pH 2; Aldrich) using a linear gradient of acetonitrile (CH,CN) of 0.2-39% in 13 min (3%/ min), at a flow rate of 1 .O ml/min. Peaks were detected at 206 nm using pairs of proctolin-containing neurons that innervate the STG iColeman et al., 1992). Th; includes the paired modulatory proctolin neuron (MPN; Nusbaum and Marder, 1989a,b) and the paired modulatory commissural neuron 1 (MCNl; Christie et al., 1993) . Both of these neurons excite the pyloric rhythm. METHOD MANAGER software. Control injections were made of synthetic a Knauer variable wavelength UV detector that was controlled by the peptide and peptidase inhibitors to verify retention time and to approximate the amount of material producing each peak of interest. Detection threshold for proctolin was approximately 2 x lo-l2 mol.
In corn&ration experiments, material corresponding to peaks of interest was collected during the linear gradient using a Dynamax FC-2 fraction collector (Rainin). Purified samples were dried (SpeedVac Concentrator, Savant) and resuspended in HPLC solution A (99.7% H,O, 0.2% CH,CN, and 0.1% TFA). These samples were analyzed by HPLC using the same C,, column and solvents, but under isocratic conditions. The isocractic condition for Proct. [2-51 was 18% CH,CN, while for Proct. [3-51 it was 14% CH,CN. Each resuspended fraction was halved and the following injections were made to examine each peak of interest:
(1) half of the collected peak alone, (2) an approximately equivalent amount of the putative synthetic analog, and (3) a mixture containing the other half of the collected peak and an approximately equal amount of the synthetic analog. To confirm sample identity and purity, after isocratic elution, each peak of interest was analyzed also using the original linear gradient. As a final test of sample purity, the Proct. [2-51 peak was collected again, dried, and resuspended for HPLC analysis under isocratic conditions using a second solvent system with triethylamine (TEA, pH 4.5; Pierce, Inc.) rather than TFA as the counter ion. With this solvent system, Proct. [2-51 was assayed at 13% CH,HN.
In this article we examine the fate of exogenously applied proctolin in the nervous system of the crab Cancer borealis. We have found, in biochemical experiments using the relatively large thoracic ganglion (TG), that proctolin is enzymatically degraded primarily by an aminopeptidase (AP) inhibitor-sensitive process. In complementary electrophysiological experiments, AP inhibitors enhanced the excitatory effects ofproctolin on the pyloric rhythm, suggesting that AP activity terminates the proctolin effects in the STG.
Portions of this work were published previously in abstract form (Coleman et al., 199 1) .
Materials and Methods
Animals. Cancer borealis were obtained from Neptune Seafood & Lobster Co. (Boston, MA). Crabs were maintained in refrigerated (1 O-l 2"C), aerated aquaria with filtered, circulating artificial seawater. Data were obtained from 72 male crabs weighing between 300 and 800 gm.
Solutions. C. borealis physiologi&l &line contained (mmol/l&r) NaCl, 440: KCl. 11: M&l,. 26: CaCl,. 13: Trizma base. 10: and maleic acid. 5 (pH 7.4-7.5). ?r&ol& and-ihe 'AP inhibitors amastatin, bestatinl epiamastatin, and puromycin were obtained from Sigma Chemical Co (St. Louis, MO). The AP inhibitors arphamenine B and actinonin were obtained from Peninsula Labs (Belmont, CA). Proct. [2-51 (Tyr-LeuPro-Thr) and Proct. [3-51 (Leu-Pro-Thr) were provided by Dr. James M. Weimann (Department of Biology, Brandeis University), and were synthesized using the procedure for peptide synthesis described in Weimann (1992) . Proct. [l-2] (Arg-Tyr) and additional Proct. [3-51 were synthesized by Research Genetics, Inc. (Huntsville, AL). All peptides and peptidase inhibitors were stored either as frozen or lyophilized aliquots of stock solution (1O-2 M or 10m3 M) that were diluted to the working concentration in saline immediately before they were used.
Ganglionic incubations. Because a large source of neural tissue was necessary to cleave amounts of proctolin large enough to be detected by absorbance at 206 nm, we used the TG in these experiments. After each dissection, the sheathed TG was pinned to a Sylgard (Dow Coming)-coated petri dish and preincubated for at least 30 min in 3 ml saline. Following several rinses, the TG was then incubated with either (1) saline, (2) saline plus Proct. or Pro&. [2-51 (Peptide; 1O-5 M), or (3) saline plus peptide ( 10m5 M) and peptidase inhibitor ( 1O-4 M). Each TG incubation was maintained for at least 2 hr (1 l-l 5"C) and 220 pl aliquots were removed at T = 1, 60, and 120 min. At T = 0 min, the aliquot contained 2.2 x 10m9 mol of proctolin. Aliquots immediately received 25 ~1 of HCl (1 .O M) to inactivate enzymatic activity and were then analyzed by reverse-phase high-performance liquid chromatography (HPLC; see below).
Conditioned saline incubations. Incubations of TG to generate conditioned saline (CS) involved a 30-60 min preincubation with saline, which was replaced with fresh saline (3 ml) for a subsequent 2 hr incubation. This CS was then removed and incubated with the same test solutions described above for TG incubations. All incubations of CS aliquots were performed at 13°C. Each CS aliquot was a 700 ~1 solution of CS (560 ~1) and peptide (1 Om4 M, 70 ~1) plus either peptidase inhibitor (lo-' M) or saline (70 ~1). Final concentrations in each aliquot were 1O-5 M peptide and 10m4 M inhibitor (when present). From each aliquot, HPLC samples (220 ~1) were removed at T = 1, 60, and 120 min, and immediately inactivated by adding HCl (1 .O M, 25 ~1).
HPLC. All HPLC analyses were performed using a Rabbit HPX Dual Pump Delivery System with a Dynamic Mixer (Rainin) controlled by a Macintosh SE computer using Dynamax HPLC METHOD MANAGER (version 1.3, Rainin). Sample volumes (200 ~1) contained 180 ~1 of CS HPLC data analysis. All chromatograms were stored for analysis using Dynamax METHOD MANAGER software. The peak areas for the four peaks of interest-proctolin and the three degradation products-were entered into spreadsheets for further analysis using LOTUS l-2-3, and then were imported into SIGMAPLOT (version 4.1) for graphic representation. In most cases, data were normalized by representing each peak of interest as a percentage of the summed peak area of all four peaks. However, this analysis was complicated by the fact that three of the peptidase inhibitors used for these studies shared retention times with one or another of the four peaks of interest. Thus, arphamenine B had the same retention time as Proct. [3-51, puromycin the same as Proct.
[2-51, and epiamastatin the same as proctolin on the TFA linear gradient. Therefore, some data are also represented as the absolute peak area for each peak of interest. All background peaks with the same retention time as Proct. and the Proct. fragments were subtracted from the peaks of interest before analysis and graphic representation. Background peaks were identified as those peaks that were present, with invariant size at all time points, in CS alone aliquots.
Electrophysiology. Electrophysiological experiments were performed on the isolated STNS, which includes the COGS, OG, and STG, plus their connecting and motor nerves (Fig. 1 ). The nervous system was pinned down in a Sylgard-coated petri dish, and was superfused continuously with chilled (10-14"(Z) physiological saline at a rate of 7-12 ml/min. Impulse activity from the COGS to the STG was blocked by applying isotonic sucrose (7.5 x 10-l M) to a Vaseline well surrounding each desheathed COG (Fig. 1) . The STG was superfused separately from the OG and all nerves by surrounding the STG with a Vaseline well that held approximately 0.5 ml saline (Fig. 1) . Bath volume was approximately 10 ml.
The activity of the pyloric motor pattern produced by the STG was monitored continuously by extracellular recordings from identified STG motor nerves (Nusbaum and Marder, 1989a) . Extracellular recordings were made using stainless steel wire electrodes that were pressed into the Sylgard alongside individual motor nerves and isolated from the bath by Vaseline.
To examine the effects of coapplication of proctolin and peptidase inhibitor to the STG, saline superfusion in the STG compartment was stopped, and the saline was first replaced with 500 ~1 of either saline alone or peptidase inhibitor ( 1O-5 M) dissolved in saline, and then incubated for 10 min (incubation 1). Saline alone was then replaced by either saline alone or proctolin (lo-* M or lo-' M) dissolved in saline (500 pl) and again incubated for 10 min (incubation 2). Similarly, peptidase inhibitor saline was replaced by a saline solution (500 ~1) containing the same peptidase inhibitor ( 1O-5 M) plus proctolin ( 1Om8 M), and incubated for 10 min (incubation 2). After the second incubation, saline superfusion was resumed for 45 min. During test incubations, the temperature in the STG compartment never increased by more than 3°C relative to the temperature in the outer compartment or that occurring during saline superfusion of the STG compartment.
Electrophysiology data analysis. Data were analyzed during the final minute of each application. We characterized how proctolin influenced the pyloric motor pattern by monitoring the pyloric cycle frequency and the number of spikes per burst in the lateral pyloric (LP) motor neuron. Cycle frequency was calculated as the reciprocal of the duration from the first spike in a pyloric dilator (PD) neuron burst to the first spike in the next PD neuron burst. Each analyzed segment is an average of either the cycle frequency or the number of LP spikes per burst over 10 consecutive cycles. In some experiments (N = 5) proctolin (lo-' M) caused little (~0.1 Hz) or no increase in pyloric cycle frequency. We did not include the results from these experiments in our analysis of changes in cycle frequency during application of different peptidase inhibitors. All data were entered into SIGMAPLOT for graphic representation.
Statistics. All statistical analyses were performed using GBSTAT (version 3.0). Statistical significance was determined by using either Student's t test or, for three or more test conditions, analysis of variance (ANOVA). Tukey's t test was used for post hoc multiple comparisons of ANOVA, with a critical level of a = 0.05. All data are presented as mean + standard deviation (SD). Statistical analyses of the data in Tables 2-5 were performed by comparing the difference between incubation 2 and incubation 1 for each experimental condition relative to this difference for the control condition (lo-* M or lo-' M proctolin in saline without any inhibitors, as indicated in each table) .
The proctolin data from Tables 2 and 3, and those from Tables 4  and 5 , were obtained from separate experiments. In each case, the proctolin data were obtained from the same preparations as were the other data in the same table.
Results
Proctolin degradation Incubations of proctolin with the TG, followed by HPLC analysis of aliquots of the incubate at 1,60, and 120 min time points, revealed that the amount of proctolin present in the incubate diminished over the course of 2 hr (N = 4; Fig. 2A ). In contrast, when the same amount of proctolin was incubated under the same conditions with saline alone, the size ofthe HPLC-detected proctolin peak remained constant over a 2 hr period (not shown).
In parallel with the reduction in the size of the proctolin peak during TG incubations there appeared three novel HPLC-detected peaks, called putative proctolin fragments l-3 (PPF-1, PPF-2, PPF-3) which increased in size with incubation time (Fig. 2A) . Thus, at T = 1 min, nearly all (97%) of the analyzed peak area resulted from proctolin. At T = 120 min, only 82% of this area was due to the proctolin peak and the remaining 18% resulted from the PPF peaks. The concomitant decrease in the proctolin peak and increase in three novel peaks suggested that proctolin was being degraded by the TG and that the novel peaks were the resulting proctolin degradation products (see below).
PPF-1, the largest of the three novel HPLC-detected peaks, had a retention time on the linear gradient of 13.3 min, and thus eluted immediately before the proctolin peak, which had a retention time of 13.7 min (Fig. 2) . PPF-2 and PPF-3 had retention times of 11.9 min and 10.6 min, respectively (Fig. 2) .
Generally, no PPF-2 or PPF-3 was detected in the T = 1 min aliquot. In contrast, the T = 1 min aliquot routinely showed a small but discernable peak at the PPF-1 retention time (Fig. 2) . This peak, however, resulted from background absorbance as it was also present in control (CS alone) HPLC injections (Fig.   2B , top trace).
We examined the extent to which the proctolin-degrading activity was released into the saline. To this end, we produced Figure 1 . Schematic diagram of the stomatogastric nervous system (STNS) of the crab Cancer borealis. The paired commissural ganglia (COG) were surrounded by Vaseline wells (heavy lines) and the saline inside the wells was replaced with isotonic sucrose (7.5 x 10-l M). The stomatogastric ganglion (STG) was surrounded by a separate Vaseline well. The STG was superfused separately from the remainder of the STNS. Shaded region in each ganglion represents the neuropil. In the STG, the neuropil is surround by the neuronal somata. Three lines entering the neuropil represent the axons of neurons innervating the STG from COGS and OG. dgn, dorsal gastric nerve; dvn, dorsal ventricular nerve; ion, inferior esophageal nerve; fvn, lateral ventricular nerve; mvn, medial ventricular nerve; OG, esophageal ganglion; son, superior esophageal nerve; stn, stomatogastric nerve.
conditioned saline from the TG, after which this CS was incubated with proctolin (see Materials and Methods; N = 20) . Similar to its incubation with the TG, the proctolin peak diminished over time with CS incubation and the same three novel peaks were the only nonproctolin peaks to change with time ( Fig. 2B) . Surprisingly, the CS was as effective in degrading proctolin as was incubating the peptide directly with the TG itself (p > 0.05 Table 1 ). As shown by the aggregate data (N = 20) in Figure 3 , the amount of each PPF produced in CS at T = 60 min and 120 min was significantly greater than that produced at T = 1 min. At all time points, the size of the PPF-1 peak was greater than either of the other two novel peaks. Concomitantly, there was a significant reduction in the proctolin peak at these later time points. Thus, the amount of the initial proctolin aliquot (1.8 -t 0.15 nmol) remaining at T = 60 min was 1.66 f 0.12 nmol, while there was 1.55 + 0.14 nmol remaining at T = 120 min. For these experiments, during the 120 min incubations, the proctolin degradation rate was approximately 0.19 nmol/liter/sec The ability of the TG to produce conditioned saline that effectively degraded proctolin was not limited to the first 2 hr incubation. In three experiments, three successive conditioned 5.9 93.1 T=120min.
1.0 I:2 11.6 86.3 Figure   2 . Proctolin (1O-5 M) degradation resulting from incubation with the TG (A) and conditioned saline (C'S, B). In each case, HPLC chromatograms show proctolin degradation at different time points. With increasing incubation time, the putative proctolin fragment (PPF) peaks increased in size. All unlabeled peaks are background peaks that are unrelated to proctolin. Peaks were analyzed at 206 nm. Peak 3, PPF-3 (RY); penk 2, PPF-2 (LPT); peak I, PPF-1 (YLPT); peak P., proctolin (RYLPT = Arg-Tyr-Leu-Pro-Thr).
salines were produced, each one involving a 2 hr incubation with the same TG (Fig. 4) . In each of these experiments, we found that CS 3 was essentially as effective as CS 1 in reducing the size of the proctolin peak and increasing the size of the PPF peaks on HPLC.
Idenbjication of proctolin degradation products We reasoned, by comparing the above results with those of earlier studies of proctolin degradation in insect neural tissue (Quistad et al., 1984; Isaac, 1987) , that the PPFs were likely to [2-51. To study this latter possibility, we incubated synthetic Proct. [2-51 (7 x 10m9 mol) both with the TG and with CS, using the same protocols and HPLC analysis that were used for proctolin incubations. Both TG (N = 3; data not shown) and CS (N = 4; Fig. 6 ) degraded Proct. [2-51 and produced Proct.
[3-51. After 2 hr CS incubations, 94.3 f 2.2% of the total peak area was Proct. [2-51 (Fig. 6 ) as compared with approximately 88% being due to the proctolin peak (Table 1) proctolin incubations. Thus, after these 2 hr incubations, aliquots contained 1.59 f 0.07 nmol of Proct. [2-51, while aliquots at T = 0 min contained 1.80 f 0.19 nmol. This resulted in a degradation rate of approximately 0.22 nmol/liter/sec, which was similar to the proctolin degradation rate (0.19 nmol/liter/ set). As shown in Figure 6 , there were increasing amounts of Proct. [3-51 produced over the course of the 2 hr incubations. Thus, Proct. [3-51 could be produced by serial N-terminal cleavage of proctolin. In contrast to the proctolin incubation experiments, no Proct. [l-2] was produced from the Proct. [2-51 incubations.
Aminopeptidase inhibitors diminish proctolin degradation Proctolin had been shown to be sensitive to AP activity (Quistad et al., 1984; Isaac, 1987) so we tested the ability of six different AP inhibitors to prevent proctolin degradation by CS. As shown in Figures 7 and 8 , each AP inhibitor that we tested was able to prevent at least partially the reduction in the size of the proctolin peak and/or the appearance of one or more of the proctolin fragment peaks. For the inhibitors amastatin, acti- 8A) . Because of overlap of HPLC retention times with peaks of interest, data for the other three inhibitors could only be analyzed as peak areas (see Materials and Methods; Fig. 8B ). When we compared these peaks with those resulting from incubation of proctolin without inhibitor, we found that each of these inhibitors significantly decreased the amount of proctolin degradation (Fig. 8) . In terms of the size of either the proctolin peak or that of Proct. [2-51, amastatin and actinonin were equally effective and were more effective than bestatin. For example, after 2 hr incubations, 88% of the total peak area was proctolin when no inhibitors were present, while 93% was proctolin when bestatin was also present and 98% was proctolin when either amastatin or actinonin was present (Fig. 8A) . Interestingly, the ability of each inhibitor to prevent the appearance of Proct. [2-51 did not necessarily correlate with the ability of that inhibitor to block the appearance of Proct. [3-51 and Proct. [l-2] . Thus, relative to CS alone, only actinonin significantly reduced the amount of both Proct. [3-51 and Proct. [l-2] (Figs. 7, 8 ). While amastatin also significantly reduced the size of the Proct. [3-51 peak, it did not change the size of the Proct. [l-2] peak relative to CS alone (Figs. 7, 8) . Additionally, whereas bestatin and arphamenine had little influence on Proct.
[3-51, their presence produced a slight increase in the Proct. [l-21 peak size (Fig. 8B) . Puromycin did not alter the size of either the Proct. [3-51 or Proct. [l-2] peaks.
Like proctolin degradation, the Proct. [2-51 degradation was also amastatin sensitive. Thus, after 120 min co-incubations of Proct. [2-51 plus amastatin in CS, the Proct. [2-51 peak was indistinguishable from that of controls (percentage total peak area, 99.1 f 0.2%; N = 4) and only trace amounts (< 1%) of Proct. [3-51 were detected. In contrast, approximately 6% of the peak area was represented by the Proct. [3-51 peak after 120 min incubations of Proct. [2-51 with CS alone (Fig. 6 ). This amastatin-sensitive degradation of Proct. [2-51 presumably accounts for the decrease in the Proct. [3-51 peak that occurred from proctolin incubations in CS plus amastatin. No other inhibitor was tested on Proct. [2-51 degradation.
Proctolin actions are enhanced by aminopeptidase inhibitors
To test the physiological role of the AP activity identified in our biochemical studies, we examined the ability of the AP inhibitors used in these biochemical studies to influence the modulatory effects of proctolin on the pyloric motor pattern in the stomatogastric ganglion. The experimental setup is illustrated in Figure 1 and is described in the Materials and Methods. We reasoned that if the AP inhibitors effectively prevented proctolin degradation, then they should enhance the proctolin-mediated excitation of the pyloric motor pattern in the STG. To test this hypothesis, we applied each AP inhibitor (1 O-5 M) with proctolin (1 Om8 M). As predicted, many of these inhibitors did enhance the proctolin excitation of the pyloric motor pattern (Figs. 9, 10; Tables 2, 3: incubation 2 vs 1). In contrast, none of these inhibitors influenced the pyloric motor pattern when applied alone (Tables 2, 3 : incubation 1). The enhanced excitation that occurred when these inhibitors were coapplied with proctolin included (1) a faster pyloric motor pattern, and (2) more intense impulse bursts in several pyloric neurons. For example, in the experiment shown in Figure 9 , bestatin only slightly enhanced the proctolin-mediated excitation of the pyloric rhythm, but amastatin increased this activity such that it was equivalent to that occurring in the presence of a IO-fold higher concentration of proctolin. Only the peptidase inhibitors amastatin and arphamenine B significantly increased the pyloric cycle frequency relative to proctolin (1 Om8 M) alone (Table 2) . While the effects of actinonin on cycle frequency appeared to be comparably large, they were only studied in two experiments (Table 2) . In contrast, all five inhibitors enhanced the number of LP neuron impulses per burst as compared with proctolin ( 1O-8 M) alone (Fig. 10, Table 3 ). Bestatin and arphamenine B, however, were less effective than actinonin, epiamastatin, and amastatin, all of which enhanced the effects of lo-* M proctolin on LP neuron activity such that it was indistinguishable from that resulting from application of lo-' M proctolin (Fig. 10 , Table 3 ).
Physiological actions of proctolin degradation products
To test whether the observed proctolin cleavages were inactivating the peptide, we studied the effects on the pyloric motor pattern of bath applying each identified proctolin degradation product to the STG. As shown in Figure 11 , when we applied Proct. [2-51 in the concentration range where the parent peptide effectively excites the pyloric rhythm ( 10m9 M to 1O-6 M), there was no effect on this motor pattern. However, higher doses of Proct. [2-51 (> 10m6 M) did excite the pyloric rhythm (n = 3-5). This effect was moderately strong for applications of 1O-5 M Proct. [2-51 and it was particularly strong for applications of 5 x 1O-5 M (Fig. 11) . These latter effects were indistinguishable from those of lower doses of the parent peptide (lo-' M proctolin; Fig. 1, Tables 4, 5) . In contrast to the results with Proct. . The size of the proctolin peak and that of peak I were both reduced with aminopeptidase inhibitors present when compared with CS plus proctolin alone. Additionally, peak 2 was reduced by amastatin and actinonin, while peak 3 was reduced by actinonin. Best., bestatin; Actin., actinonin; Amast., amastatin; Proct., proctolin.
[2-51, bath application of even higher doses ( 10e4 M) of Proct.
[l-2] and Proct. [3-51 had no effect on the pyloric rhythm (N = 4; data not shown).
Discussion
Proctolin degradation by conditioned saline In this study we have shown that the pentapeptide proctolin is cleaved by the crab nervous system. This cleavage is mediated primarily by AP activity, although there appears to be some DAP-like activity as well. Surprisingly, we found that saline preincubated with the TG had nearly as much proctolin-cleaving activity as the TG. Thus, nearly all of the proctolin-cleaving activity was probably released into the extracellular space rather than remaining tightly bound to ganglionic membranes. There are several possible explanations for the generation of proctolin-degrading activity in the CS. For example, this activity might have resulted from exocytosis. Alternatively, the activity might have been tethered to the extracellular surface of ganglionic membranes by a labile linkage that was continually cleaved. Neither of these possibilities was examined in our experiments. However, there is precedence for the latter possibility in that other cell surface enzymes, including acetylcholinesterase, are membrane anchored via a phospholipase C-sensitive, glycosylphosphatidylinositol linkage (Futerman et al., 1985; Haas et al., 1988; Low and Saltiel, 1988) . Such a linkage also exists for at least one AP, aminopeptidase P (AP-P, EC 3.4.11.9; Hooper and Turner, 1988) .
Multiple proctolin-degrading enzymes? Our results are consistent with proctolin cleavage in the crab nervous system being mediated by at least two different enzymes. The major proctolin-degrading activity appears to be an AP, since most of the proctolin cleavage is suppressed by AP inhibitors, and our HPLC comigration experiments indicate that the major AP inhibitor-sensitive degradation product is Proct. [2-51.
The second proctolin-degrading activity appears to be a DAP. This conclusion is based primarily on the coappearance of Proct. Identity of the proctolin-cleaving peptidases Previous workers (McDonald and Barrett, 1986; Turner et al., 1989) have characterized four distinct mammalian APs that show some similarity to the proctolin-cleaving activity that we have described in the crab nervous system. These include leutine AP (LAP; EC 3.4.1 l.l), aminopeptidase M (AP-M; EC 3.4.11.2), aminopeptidase B (AP-B; EC 3.4.11.6), and aminopeptidase A (AP-A, EC 3.4.11.7). Each of these peptidases exhibits different substrate and inhibitor specificities. Of these enzymes, the likeliest ones to degrade proctolin effectively are LAP, AP-M, and AP-B. Purified mammalian LAP has been shown to cleave proctolin effectively in solution, although the cleavage products were not identified (Brown, 1977; Davis et al., 1989) . The preferred substrates for both AP-M and AP-B include peptides, such as proctolin, with an N-terminal arginine (McDonald and Barrett, 1986; Turner et al., 1989) . Each ofthese APs, however, has been reported to have an inhibitor-sensitivity profile that is distinct from that of the proctolin-sensitive AP activity seen by us in the crab (Umezawa and Aoyagi, 1983; McDonald and Barrett, 1986) . It is, however, possible that the AP activity in our study represents several different enzymes with overlapping inhibitor sensitivities, rather than a single AP. Supporting this possibility is our finding that the crab AP ac- Activity of an ongoing pyloric motor pattern from a single experiment is monitored by extracellular recordings of a pyloric motor nerve, the dvn (see Fig. 1 ). LP, lateral pyloric constrictor motor neuron; PY, pyloric constrictor motor neuron; PD, pyloric dilator motor neuron.
tivity was approximately equally inhibited by amastatin, actinonin, puromycin, and epiamastatin. Previous work in the insect nervous system showed that extracellular proctolin is a substrate of AP activity and that its degradation was most effectively inhibited by amastatin (Quis- Isaac, 1987) . However, other aspects of the inhibitor profile determined by Isaac (1987) for the proctolincleaving AP activity of insect neural membrane fractions differed from that of the AP activity described in the present study. Proctolin was also degraded by DAP activity in these previous studies, although the particular DAP responsible for this degradation was not identified (Quistad et al., 1984; Isaac, 1987) . However, Hui (1988) reported that proctolin is readily cleaved by DAP V. DAP V, purified from rat brain membranes, strongly prefers peptides with an arginine residue at the N-terminus, including proctolin. 4.3 + 1.6*+ 4.3 + 1.7 6.6 f 2.7t 5.6 -+ 3.3 9.1 f 3.4*t 3.6 rt 2.0 8.0 + 2.5*t 5.6 +-2.6 11.2 zk 3.2* 4.0 J-2.1 9.9 IIZ 3.2* 5.5 z!I 2.0 11.6 * 2.9* 4.5 rfi 2.1 12.6 I!I 3.5* Details are as for 5 Am lo-'M Pr P'; P'r P'r P'r P'; Pr Physiological role of proctolin-cleaving peptidases Our results are consistent with there being extracellularly located AP activity within the STG that terminates the neural actions of proctolin. This conclusion is based on the fact that the same AP inhibitors that effectively suppressed proctolin degradation in our biochemical experiments were able to enhance the excitatory effects of bath-applied proctolin in our electrophysiological experiments. Although we analyzed the enzymatic degradation of proctolin using a different ganglion than we used to monitor its electrophysiological effects, the order of effectiveness of the peptidase inhibitors used in both types of experiments was similar. In addition to the proctolin-degrading activity reported by us to reside within the crab nervous system, there is previously reported proctolin-degrading activity within the crustacean hemolymph. Schwarz et al. (1984) reported that, in preliminary experiments where they injected exogenous proctolin in the hemolymph of the lobster Homarus americanus, proctolin was degraded with a half-life of 6-10 min. Proctolin cleavage also occurs in insect hemolymph (Steele and Stat-rat& 1985) . Because the STG is located within a major artery, any neurally released proctolin that was not degraded by ganglionic enzyme activity would likely be degraded in the hemolymph. Our experiments Saline (n = 6) 1O-8 M proctolin (n = 7) lo-' M proct. Saline (n = 6) 4.3 + 1.0 4.4 * 0.7 3.8 k 0.9t lo-* M proctolin (n = 7) 4.9 k 1.9 5.1 + 1.7 6.8 + 1.8t lo-' M proct. [2-51 (n = 3) 3.8 + 2.5 3.4 + 2.0 3.2 f 1.1t 1O-6 M proct. [2-51 (n = 4) 4.3 -t 2.8 4.6 + 2.5 5.2 k 2.8t 1O-5 M proct. [2-51 (n = 4) 4.6 k 3.9 4.4 * 3.1 7.2 + 3.4-f 5 x 1O-5 M proct. [2-51 (n = 5) 5.7 +-2.4 4.5 f 2.3 11.8 zk 1.7* lo-' M proctolin (n = 10) 4.3 k 2.7 4.6 k 2.3 12.9 + 3.2* Details are as for Table 2. do not enable us to predict which of these two sources of proctolin-degrading activity would be larger. We were surprised to find that proctolin was only approximately 500-fold more effective than Proct. [2-51 in exciting the pyloric motor pattern. An earlier study by Starratt and Brown (1979) using a proctolin-sensitive muscle assay, showed that proctolin was > lo6 x more effective than Proct. [2-51. Whether this difference results from different proctolin receptors, differential sensitivities to resident peptidases, or differential access to receptors remains to be determined.
The proctolin degradation reported in the present study may well contribute to the relatively short-lasting excitatory effects of two proctolin-containing neurons, MPN and MCNl, on the pyloric motor pattern in the crab STG (Nusbaum and Marder, 1989a,b; Nusbaum et al., 1992; Christie et al., 1993; Coleman and Nusbaum, 1994) . Whereas some modulatory neurons have effects that long outlast their period of impulse activity (HarrisWarrick et al., 1992b) , the effects of both MPN and MCNl subside within seconds after their activity is terminated (Nusbaum and Marder, 1989a,b; Nusbaum et al., 1992) . Because the effects of the proctolin neurons on the pyloric rhythm are equivalent to bath application of 10m7 M to 1O-6 M proctolin and threshold for proctolin actions on this system is approximately 1O-9 M (Marder et al., 1986; Nusbaum and Marder, 1989b) , the local concentration of neurally released proctolin probably decreases by 2-3 orders of magnitude within several seconds or less. Such a rapid decrease in local proctolin concentration would be facilitated by the proctolin-cleaving actions identified in the present study. Finally, since many extracellularly located peptidases cleave more than one neuropeptide (Turner et al., 1985; Turner, 1987) , it is possible that the peptidase activities documented in this study also degrade other neurally released peptides in the crustacean nervous system. 
